Thomas M Durcan Selected Research

Thomas M Durcan Research Topics

Disease

24	Parkinson Disease (Parkinson's Disease) 03/2024 - 01/2011
8	Synucleinopathies 10/2023 - 01/2017
7	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 01/2012
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 07/2021 - 01/2020
3	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2013 - 01/2011
2	Neoplasms (Cancer) 01/2024 - 01/2020
2	Autism Spectrum Disorder 10/2023 - 01/2019
2	Dementia (Dementias) 09/2023 - 11/2022
2	Frontotemporal Dementia (Semantic Dementia) 01/2023 - 01/2022
2	Proteostasis Deficiencies 11/2022 - 01/2022
2	Ataxia (Dyssynergia) 01/2013 - 01/2011
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 04/2024
1	Neuraminidase 1 deficiency 04/2024
1	Mucopolysaccharidoses 04/2024
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 04/2024
1	Leukoencephalopathies 04/2024
1	Ciliopathies 01/2024
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2024
1	Disease Progression 10/2023
1	Fragile X Syndrome (Martin Bell Syndrome) 10/2023
1	Autistic Disorder (Autism) 10/2023
1	Lewy Body Disease (Lewy Body Dementia) 09/2023
1	Atrophy 11/2022
1	Nervous System Diseases (Neurological Disorders) 07/2021
1	Glioblastoma (Glioblastoma Multiforme) 11/2020
1	Brain Neoplasms (Brain Tumor) 11/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Intellectual Disability (Idiocy) 10/2018

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 11/2023 - 02/2011
7	SynucleinsIBA 11/2023 - 01/2021
6	alpha-SynucleinIBA 03/2024 - 01/2022
4	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2015 - 01/2011
3	EnzymesIBA 04/2024 - 01/2011
3	Glucosylceramidase (Glucocerebrosidase)IBA 03/2024 - 01/2023
3	Phosphotransferases (Kinase)IBA 01/2024 - 05/2015
3	Ligases (Synthetase)IBA 05/2015 - 01/2013
3	Ataxin-3IBA 01/2013 - 01/2011
2	HydrolasesIBA 03/2024 - 11/2023
2	Cathepsin BIBA 03/2024 - 11/2023
2	Deubiquitinating EnzymesIBA 11/2023 - 01/2012
2	PrionsIBA 10/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2021
2	RNA (Ribonucleic Acid)IBA 09/2023 - 01/2023
2	Peptides (Polypeptides)IBA 07/2021 - 01/2021
2	polyglutamineIBA 01/2013 - 01/2011
1	polysialic acidIBA 04/2024
1	Cathepsin AIBA 04/2024
1	GalactosidasesIBA 04/2024
1	Glycoproteins (Glycoprotein)IBA 04/2024
1	GlycosaminoglycansIBA 04/2024
1	SulfatasesIBA 04/2024
1	Neuraminidase (Sialidase)IBA 04/2024
1	Polysaccharides (Glycans)IBA 04/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2024
1	PTEN-induced putative kinaseIBA 03/2024
1	ChaperoninsIBA 11/2023
1	Fragile X Mental Retardation ProteinIBA 10/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2023
1	Protein AggregatesIBA 09/2023
1	c-Mer Tyrosine KinaseIBA 09/2023
1	Messenger RNA (mRNA)IBA 09/2023
1	DipeptidesIBA 01/2023
1	GalactosylceramidaseIBA 01/2023
1	C9orf72 ProteinIBA 01/2023
1	Molecular Chaperones (Chaperone, Molecular)IBA 11/2022
1	Intrinsically Disordered ProteinsIBA 11/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2022
1	Amyloid beta-PeptidesIBA 07/2021
1	Tetracycline (Achromycin)FDA LinkGeneric 07/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Dendrimers (Dendrons)IBA 11/2020
1	Conditioned Culture MediaIBA 11/2020
1	Sulfates (Sulfates, Inorganic)IBA 11/2020
1	polyglycerolIBA 11/2020
1	Biocompatible Materials (Biomaterials)IBA 01/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2018

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2018
1	Precision Medicine 04/2024